1-3 of 3
Biswajit Dubashi
Close
Sort by
Journal Articles

Pomalidomide, Bortezomib, and Dexamethasone Combination Chemotherapy for Newly Diagnosed Multiple Myeloma: Pomace Phase II Study

Fen Saj, Prasanth Ganesan, Smita Kayal, Biswajit Dubashi
Journal: Blood
Blood (2022) 140 (Supplement 1): 12612.
https://doi.org/10.1182/blood-2022-165013
Published: 2022
Journal Articles

Covid-19 Infection in Hematological Malignancies: Registry Data from India

Arihant Jain, Lingaraj Nayak, Uday Prakash Kulkarni, Nikita Mehra, Uday Yanamandra, Smita Kayal, Sharat Damodar, Joseph M John, Suvir Singh, Prashant Mehta, Pritesh Munot, Sushil Selvarajan, Venkatraman Radhakrishnan, Rajan Kapoor, Biswajit Dubashi, Bharath Ram S, Hasmukh Jain, Jayachandran PK, Jeyaseelan Lakshmanan, Thenmozhi Mani, Om Prakash, Jayashree Thorat, Satyaranjan Das, Biju George, Deepesh Lad, Pankaj Malhotra
Journal: Blood
Blood (2021) 138 (Supplement 1): 1938.
https://doi.org/10.1182/blood-2021-149100
Published: 2021
Journal Articles

Increased Risk of Early Hematologic Toxicity during Maintenance Therapy in Acute Lymphoblastic Leukemia Patients of South Indian Origin Carrying NUDT15*3 Allele

Sunitha Kodidela, PhD, Dorababu Patchva, PhD, Dimpal Thakkar:, PhD, Biswajit Dubashi, DM, Rajan Sundaram, M.Sc, Ravi Prasad Nidanapu, PhD, Muralidharan Nivedita, PhD, Anil Aribandi, MD MRCP, FRCPath, Suresh Chandra Pradhan, MD, Chakradhara RS Uppugunduri, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5059.
https://doi.org/10.1182/blood-2019-129967
Published: 2019